Company Information & Drug Savings for Servier Pharmaceuticals Medications

Servier Pharmaceuticals is the US subsidiary of Servier, a French pharmaceutical company. The company focuses on oncology and cardiometabolic diseases, with products including Tibsovo (ivosidenib) for AML and cholangiocarcinoma with IDH1 mutations, and Oncaspar for acute lymphoblastic leukemia. Servier’s oncology research targets cancer metabolism and cell signaling.